KPNB1 and glioblastoma: In glioblastoma research, KPNB1 knockdown inhibited β-catenin nuclear import, resulting in the inactivation of the Wnt/β-catenin signaling pathway and the arrest of proliferation [15], and targeting KPNB1 alleviated TRAIL resistance [19].